You are here

  • Home
  • Archive
  • Volume 3, Issue 3
  • Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial

Citation Tools

Article menu

Download PDFPDF

XML
Emergency medicine
Research
Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Cannon CM, Levy P, Baumann BM, et al
Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial
BMJ Open 2013;3:e002338. doi: 10.1136/bmjopen-2012-002338